Clinical Trial

Anti-Migration System for Anti-reflux Oeso-gastric Stent (ANTIMIG)

Study acronym: ANTIMIG
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 30, 2024 (before its estimated September 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this prospective, controlled, randomized, multicentre, single-blind study is to compare the rate of intragastric migration of 2 types of esophageal stents with and without an anti-migration device placed for locally advanced or metastatic malignant stenosis of the gastroesophageal junction.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT05431738
Lead Sponsor Société Française d'Endoscopie Digestive
Conditions Stent Migration, GastroEsophageal Cancer
Enrollment 180 participants
Start Date 2022-09-01
Primary Completion 2025-09-01 (estimated)
Study Completion 2025-09-01 (estimated)
Updated on ClinicalTrials.gov 2024-07-30